Syringe Co. Asks Justices To Review $340M Antitrust Reversal
Syringe maker Retractable Technologies Inc. has urged the U.S. Supreme Court to review the reversal of a $340 million award for antitrust and false advertising claims against rival Becton Dickinson &...To view the full article, register now.
Already a subscriber? Click here to view full article